115 results
424B3
KA
Kineta Inc
13 Nov 23
Prospectus supplement
5:28pm
have referred you. Neither we nor the selling securityholder take responsibility for, and can provide no assurance as to the reliability of, any other
8-K
EX-10.1
rmf66
5 Oct 23
Kineta, Inc. Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:05pm
424B5
hw7fj15hv ks8p71
5 Oct 23
Prospectus supplement for primary offering
10:47am
8-K
EX-99.1
as03mwss jc5w745awq
29 Jun 23
Kineta to Receive $5 Million Milestone Payment from Merck
7:01am
8-K
stcmsv
29 Jun 23
Kineta to Receive $5 Million Milestone Payment from Merck
7:01am
8-K
EX-99.1
5uyg vu5bfkqw
28 Jun 23
Departure of Directors or Certain Officers
7:00am
424B3
8bd5c53m
12 Jun 23
Prospectus supplement
5:01pm
8-K
EX-10.1
8l4zyfn3pm4f
21 Apr 23
Kineta, Inc. Announces $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
5:16pm
424B5
xhj5 nenh9x08
21 Apr 23
Prospectus supplement for primary offering
5:14pm
8-K
EX-10.6
6z8 dh8grm
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm